Swedish Orphan Biovitrum AB has published its 2025 Annual and Sustainability Report, highlighting the company’s achievements in advancing innovative therapies for people living with rare diseases. Sobi continues to prioritize …
The share repurchases are part of the buyback programme announced by Truecaller on 30 May 2025. This programme is scheduled to run from 30 May 2025 until the company’s Annual …
